MaxCyte (LSE:MXCT) Marketable Securities : £88.92 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is MaxCyte Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. MaxCyte's Marketable Securities for the quarter that ended in Mar. 2025 was £88.92 Mil.

MaxCyte's annual Marketable Securities declined from Dec. 2022 (£177.56 Mil) to Dec. 2023 (£96.21 Mil) but then increased from Dec. 2023 (£96.21 Mil) to Dec. 2024 (£100.14 Mil).

MaxCyte Marketable Securities Historical Data

The historical data trend for MaxCyte's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MaxCyte Marketable Securities Chart

MaxCyte Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

11.91

155.86

177.56

96.21

100.14

MaxCyte Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															106.45	94.18	88.36	100.14	88.92

MaxCyte Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

MaxCyte (LSE:MXCT) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

MaxCyte Marketable Securities Related Terms

Thank you for viewing the detailed overview of MaxCyte's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

MaxCyte Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (LSE:MXCT) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

MXCT:USA MYE0:Germany

Address

9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850

Website

https://www.maxcyte.com

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.